Search
for

    Glossary Venlafaxine

    prescription medication for depression and anxiety, known as Effexor

    Venlafaxine, also known by the brand name Effexor, is a prescription medication primarily used to treat major depressive disorder, anxiety, and panic disorder. It belongs to a class of drugs called serotonin-norepinephrine reuptake inhibitors (SNRIs), which work by increasing the levels of serotonin and norepinephrine, neurotransmitters that help regulate mood and anxiety.

    Sort by

    Research 30 of 94

    1. Urinary Incontinence due to Overactive Detrusor Muscle: A Rare Side Effect of Venlafaxine Case Reports in Urology · 2015 · 4 citations
    2. Venlafaxine induced hair loss: a case report Düşünen Adam · 2016 · 2 citations
    3. Cerebral Ischemia Related to Isotretinoin; Venlafaxine-Induced Alopecia; Cognitive Dysfunction with Tolterodine; Retinal Artery Occlusion after Injection of Long-Acting Risperidone; Olanzapine-Induced Chylomicronemia Presenting as Pancreatitis; Metabolic Effects of the Atypical Antipsychotics – an Editorial; Another Drug-Induced Pancreatitis – This One Caused by a Tyrosine Kinase Inhibitor; Suicide Attempts Related to Antidepressant Medications Hospital pharmacy · 2007
    4. A CASE REPORT OF PARANOID DELUSION WITH VENLAFAXINE USE Journal of the American Geriatrics Society · 2003 · 8 citations
    5. Side effects of androgen deprivation therapy: monitoring and minimizing toxicity Urology · 2003 · 228 citations
    6. Fluoxetine- and Sertraline-Related Hair Loss in a Teenager: A Case Report Klinik Psikofarmakoloji Bulteni-bulletin of Clinical Psychopharmacology · 2013 · 5 citations
    7. Table of Contents The Brown University Psychopharmacology Update · 2006
    8. Sex differences in the hypothalamic–pituitary–adrenal axis’ response to stress: an important role for gonadal hormones Neuropsychopharmacology · 2019 · 197 citations
    9. Hair Loss in Women The New England Journal of Medicine · 2007 · 129 citations
    10. Adverse Cutaneous Reactions to Antidepressants American Journal of Clinical Dermatology · 2002 · 44 citations
    11. Testosterone Improves Antidepressant‐Emergent Loss of Libido in Women: Findings from a Randomized, Double‐Blind, Placebo‐Controlled Trial The Journal of Sexual Medicine · 2014 · 36 citations
    12. Scalp Dysesthesia Related to Cervical Spine Disease JAMA Dermatology · 2012 · 33 citations
    13. Psychodermatology Advances in Psychosomatic Medicine · 2015 · 25 citations
    14. Obsessive-compulsive disorder in dermatology Journal der Deutschen Dermatologischen Gesellschaft · 2015 · 15 citations
    15. “Osler’s phenomenon”: misdiagnosing Cushing’s syndrome Postgraduate Medical Journal · 2003 · 11 citations
    16. Green formulation of spironolactone loaded chitosan coated nano lipid carrier for treatment of acne vulgaris: a randomized double-blind clinical trial Advanced Pharmaceutical Bulletin · 2023 · 8 citations
    17. Adverse cutaneous effects of psychotropic medications Expert Review of Dermatology · 2013 · 6 citations
    18. Dermoscopy of an osteonevus of Nanta International Journal of Dermatology · 2013 · 6 citations
    19. Medication Repurposing: New Uses for Old Drugs Journal of Pharmacy Technology · 2011 · 6 citations
    20. Severe hair loss associated with psyc hotropic drugs in psychiatric inpatients—Data from an observational pharmacovigilance program in German-speaking countries European Psychiatry · 2018 · 5 citations
    21. Debatable Topics in PCOS Patients InTech eBooks · 2018 · 2 citations
    22. Can gut flora changes be new biomarkers for depression? Frontiers in Laboratory Medicine · 2017 · 1 citations
    23. Effectiveness of Botulinum Toxin Type A for Trichodynia Associated with Hair Loss Disorders: A Retrospective Study Dermatology and Therapy · 2026
    24. Spectrum and signals of medication-associated cognitive disorder: a comprehensive disproportionality analysis with cross-database validation Frontiers in Pharmacology · 2026
    25. Corrective and Restorative Dermatology in Cancer Survivors: An Urgent Unmet Need! American Journal of Clinical Dermatology · 2026
    26. Drug-induced male infertility: a real-world study using FAERS and EudraVigilance databases Frontiers in Pharmacology · 2026
    27. Artefactual Skin Disorder: Exploring Clinical Features, Psychiatric Associations, and Contemporary Treatment Approaches: a Narrative Review Dermatology Review · 2025
    28. The skin and obesity International Journal of Dermatology Venereology and Leprosy Sciences · 2025
    29. Nanoemulgels: A new approach for the treatment of skin-related disorders International Journal of Pharmaceutical Quality Assurance · 2024
    30. Trichodynia: An Update on Definition, Etiopathogenesis, Diagnosis, and Treatment Journal of Skin and Stem Cell · 2022